Atlas Private Wealth Advisors Astrazeneca PLC Transaction History

Atlas Private Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Apr 21, 2022	SELL	$54.02 - $63.83 $5,564 - $6,574	-103 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$55.56 - $60.79 $19,223 - $21,033	-346 Reduced 77.06%	103 $6,000
Q2 2021 Aug 02, 2021	SELL	$48.42 - $60.18 $14,768 - $18,354	-305 Reduced 40.45%	449 $27,000
Q1 2021 Apr 28, 2021	BUY	$47.16 - $54.44 $19,194 - $22,157	407 Added 117.29%	754 $38,000
Q4 2020 Jan 29, 2021	SELL	$48.52 - $58.02 $24,260 - $29,010	-500 Reduced 59.03%	347 $17,000
Q3 2020 Oct 27, 2020	BUY	$53.07 - $61.1 $44,950 - $51,751	847 New	847 $46,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.